Myocardial infarction (MI): Nursing process (ADPIE)

Last updated: January 26, 2022

Myocardial infarction (MI): Nursing process (ADPIE)

Medical Surgical

Medical Surgical

Arrhythmias - Asystole: Nursing
Arrhythmias - Atrial fibrillation (Afib): Nursing
Arrhythmias - Atrial flutter (Aflutter): Nursing
Arrhythmias - Heart blocks: Nursing
Arrhythmias - Premature atrial contractions (PACs): Nursing
Arrhythmias - Premature ventricular contractions (PVCs): Nursing
Arrhythmias - Sinus tachycardia and sinus bradycardia: Nursing
Arrhythmias - Supraventricular tachycardia (SVT): Nursing
Arrhythmias - Ventricular fibrillation (Vfib): Nursing
Arrhythmias - Ventricular tachycardia (Vtach): Nursing
Arterial embolism: Nursing
Electrocardiogram (ECG) - Normal sinus rhythm (NSR): Nursing
Cardiomyopathy: Nursing
Congenital heart defects - Acyanotic: Nursing
Congenital heart defects - Cyanotic: Nursing
Endocarditis: Nursing
Heart defects that decrease pulmonary blood flow - Nursing considerations & client education: Nursing
Kawasaki disease: Nursing
Myocarditis: Nursing
Pericarditis: Nursing
Shock - Anaphylactic: Nursing
Shock - Cardiogenic: Nursing
Shock - Hypovolemic: Nursing
Shock - Neurogenic: Nursing
Shock - Obstructive: Nursing
Shock - Septic: Nursing
Valvular heart disease: Nursing
Geriatric considerations - Cardiac: Nursing
Aortic aneurysm: Nursing process (ADPIE)
Coronary artery disease (CAD) and angina pectoris: Nursing process (ADPIE)
Hypertension: Nursing process (ADPIE)
Left-sided heart failure: Nursing process (ADPIE)
Myocardial infarction (MI): Nursing process (ADPIE)
Pericardial effusion and cardiac tamponade: Nursing process (ADPIE)
Rheumatic heart disease: Nursing process (ADPIE)
Alpha-1 adrenergic blockers: Nursing pharmacology
Alpha-2 adrenergic agonists: Nursing pharmacology
Angiotensin II receptor blockers (ARBs): Nursing pharmacology
Angiotensin-converting enzyme (ACE) inhibitors: Nursing pharmacology
Antiarrhythmics: Nursing pharmacology
Antihyperlipidemics - Fibrates: Nursing pharmacology
Antihyperlipidemics - Miscellaneous: Nursing pharmacology
Antihyperlipidemics - Statins: Nursing pharmacology
Beta-adrenergic blockers: Nursing pharmacology
Calcium-channel blockers: Nursing pharmacology
Cardiac glycosides: Nursing pharmacology
Direct-acting vasodilators: Nursing pharmacology
Nitrates: Nursing pharmacology
Sympathomimetic medications: Nursing pharmacology
Adrenal insufficiency (Addison disease): Nursing
Cushing syndrome and Cushing disease: Nursing
Hyperparathyroidism: Nursing
Hypoparathyroidism: Nursing
Hypopituitarism: Nursing
Infant of a diabetic mother (IDM): Nursing
Phenylketonuria (PKU): Nursing
Diabetes insipidus: Nursing process (ADPIE)
Diabetes mellitus (DM): Nursing process (ADPIE)
Diabetic ketoacidosis (DKA): Nursing process (ADPIE)
Hyperosmolar hyperglycemic state (HHS): Nursing process (ADPIE)
Hyperthyroidism: Nursing process (ADPIE)
Hypothyroidism: Nursing process (ADPIE)
Syndrome of inappropriate antidiuretic hormone (SIADH): Nursing process (ADPIE)
Glucocorticoids and mineralocorticoids: Nursing pharmacology
Insulin: Nursing pharmacology
Medications affecting the parathyroid glands: Nursing pharmacology
Medications for antidiuretic hormone (ADH) disorders: Nursing pharmacology
Medications for thyroid disorders: Nursing pharmacology
Medications for growth hormone disorders: Nursing pharmacology
Oral antidiabetic medications - Alpha-glucosidase inhibitors: Nursing pharmacology
Oral antidiabetic medications - Biguanides and thiazolidinediones: Nursing pharmacology
Oral antidiabetic medications - DPP-4 inhibitors: Nursing pharmacology
Oral antidiabetic medications - Sodium-glucose co-transporter-2 (SGLT-2) inhibitors: Nursing pharmacology
Oral antidiabetic medications - Sulfonylureas and meglitinides: Nursing pharmacology
Amblyopia: Nursing
Cataracts: Nursing
Detached retina: Nursing
Hearing impairment and otosclerosis: Nursing
Legal blindness: Nursing
Macular degeneration: Nursing
Meniere disease: Nursing
Pharyngitis: Nursing
Strabismus: Nursing
Geriatric considerations - Sensory: Nursing
Otitis media: Nursing
Epistaxis: Nursing process (ADPIE)
Eye injury: Nursing process (ADPIE)
Glaucoma: Nursing process (ADPIE)
Tonsillitis: Nursing process (ADPIE)
Antiglaucoma medications: Nursing pharmacology
Eye anesthetics: Nursing pharmacology
Mydriatics and cycloplegics: Nursing pharmacology
Ophthalmic anti-inflammatories and anti-infectives: Nursing pharmacology
Biliary atresia: Nursing
Cholecystitis: Nursing
Cholelithiasis: Nursing
Diarrhea: Nursing
Diverticular disease: Nursing
Hepatitis: Nursing
Inflammatory bowel disease - Crohn disease and ulcerative colitis: Nursing
Intestinal obstruction: Nursing
Irritable bowel syndrome (IBS): Nursing
Jaundice: Nursing
Esophageal atresia and tracheoesophageal fistula: Nursing
Geriatric considerations - Gastrointestinal: Nursing
Hirschsprung disease: Nursing
Hyperemesis gravidarum: Nursing
Necrotizing enterocolitis: Nursing
Omphalocele and gastroschisis: Nursing
Appendicitis: Nursing process (ADPIE)
Celiac disease: Nursing process (ADPIE)
Cirrhosis: Nursing process (ADPIE)
Gastroesophageal reflux disease (GERD): Nursing process (ADPIE)
Hiatal hernia: Nursing process (ADPIE)
Pancreatitis: Nursing process (ADPIE)
Peptic ulcer disease (PUD): Nursing process (ADPIE)
Antacids: Nursing pharmacology
Antidiarrheals: Nursing pharmacology
Antiemetics: Nursing pharmacology
Antispasmodics (GI): Nursing pharmacology
Gallstone-dissolving agents: Nursing pharmacology
Gastric mucosal protective agents: Nursing pharmacology
Histamine H2 antagonists: Nursing pharmacology
Laxatives: Nursing pharmacology
Medications for hepatic encephalopathy: Nursing pharmacology
Pancreatic enzyme replacements: Nursing pharmacology
Proton pump inhibitors (PPIs): Nursing pharmacology
Treatment for Helicobacter pylori: Nursing pharmacology
Weight loss medications: Nursing pharmacology
Chronic kidney disease (CKD): Nursing
Dialysis care: Nursing
Epididymitis: Nursing
Glomerulonephritis: Nursing
Nephrotic syndrome: Nursing
Polycystic kidney disease (PKD): Nursing
Pyelonephritis: Nursing
Renal and urinary calculi: Nursing
Urinary retention: Nursing
Bladder exstrophy: Nursing
Circumcision: Nursing
Cryptorchidism: Nursing
Enuresis: Nursing
Geriatric considerations - Urinary: Nursing
Hypospadias and epispadias: Nursing
Acute kidney injury (AKI): Nursing process (ADPIE)
Benign prostatic hyperplasia (BPH): Nursing process (ADPIE)
Urinary incontinence - Stress: Nursing process (ADPIE)
Urinary tract infections (UTIs): Nursing process (ADPIE)
Diuretics - Osmotic and carbonic anhydrase inhibitors: Nursing pharmacology
Diuretics - Thiazide, thiazide-like, loop, and potassium-sparing diuretics: Nursing pharmacology
Antispasmodics (GU): Nursing pharmacology
Cholinergic therapy (GU): Nursing pharmacology
Anemia - Aplastic: Nursing
Anemia - Iron-deficiency: Nursing
Anemia - Macrocytic: Nursing
Disseminated intravascular coagulation (DIC): Nursing
Neutropenia: Nursing
Polycythemia: Nursing
Thalassemia: Nursing
Thrombocytopenia: Nursing
Arterial blood gas (ABG) - Overview: Nursing
Arterial blood gas (ABG) - Metabolic acidosis: Nursing
Arterial blood gas (ABG) - Respiratory alkalosis: Nursing
Blood cultures: Nursing
Cardiac biomarkers - Creatine kinase (CK): Nursing
Cardiac biomarkers - Troponin: Nursing
Coagulation studies - Partial thromboplastin time (PTT): Nursing
Complete blood count (CBC) - Hemoglobin and hematocrit: Nursing
Complete blood count (CBC) - Platelets: Nursing
Complete blood count (CBC) - Red blood cells (RBC): Nursing
Complete blood count (CBC) - White blood cells (WBC) and differential: Nursing
Complete metabolic panel (CMP) - Blood urea nitrogen (BUN) and creatinine (Cr): Nursing
Complete metabolic panel (CMP) - Chloride: Nursing
Complete metabolic panel (CMP) - Estimated glomerular filtration rate (eGFR): Nursing
Complete metabolic panel (CMP) - Glucose: Nursing
Complete metabolic panel (CMP) - Liver function tests (LFT): Nursing
Complete metabolic panel (CMP) - Potassium: Nursing
Complete metabolic panel (CMP) - Sodium: Nursing
Hemolytic disease of the fetus and newborn: Nursing
Hemolytic uremic syndrome: Nursing
Hemophilia: Nursing process (ADPIE)
Leukemia: Nursing process (ADPIE)
Sickle cell disease: Nursing process (ADPIE)
Anticoagulants - Direct thrombin and factor Xa inhibitors: Nursing pharmacology
Anticoagulants - Heparin: Nursing pharmacology
Anticoagulants - Warfarin: Nursing pharmacology
Antihyperlipidemics - Bile acid sequestrants and cholesterol absorption inhibitors: Nursing pharmacology
Antiplatelet agents: Nursing pharmacology
Blood products: Nursing pharmacology
Hematopoietic growth factors: Nursing pharmacology
Hemostatics: Nursing pharmacology
Iron preparations: Nursing pharmacology
Thrombolytics: Nursing pharmacology
Immune response - Adaptive: Nursing
Autoimmunity: Nursing
Human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS): Nursing
Hypersensitivity reactions - Type I: Nursing
Hypersensitivity reactions - Type II: Nursing
Hypersensitivity reactions - Type III: Nursing
Hypersensitivity reactions - Type IV: Nursing
Inflammatory process: Nursing
Immune response - Innate: Nursing
Immunodeficiency disorders - Primary: Nursing
Scleroderma: Nursing
Immunodeficiency disorders - Secondary: Nursing
Sjögren syndrome: Nursing
Systemic lupus erythematosus (SLE): Nursing
Toxic shock syndrome (TSS): Nursing
Erythema infectiosum (Fifth disease): Nursing
Fever: Nursing
Infectious mononucleosis: Nursing
Mumps (Parotitis): Nursing
Neonatal sepsis: Nursing
Pertussis: Nursing
Poliomyelitis: Nursing
Postpartum infections: Nursing
Roseola (Exanthem subitum): Nursing
Rubella (German measles): Nursing
Rubeola (Measles): Nursing
Smallpox: Nursing
Zika virus: Nursing
Anaphylaxis: Nursing process (ADPIE)
Lyme disease: Nursing process (ADPIE)
Rheumatoid arthritis (RA): Nursing process (ADPIE)
Antirejection immunosuppressants: Nursing pharmacology
Biologic agents: Nursing pharmacology
Vaccines: Nursing pharmacology
Immunoglobulins: Nursing pharmacology
Immunosuppressants for autoimmune diseases: Nursing pharmacology
Immunomodulators: Nursing pharmacology
Disease-modifying therapy for multiple sclerosis: Nursing pharmacology
Acne: Nursing
Animal and snake bites: Nursing
Burn injury: Nursing
Cutaneous fungal infections: Nursing
Erysipelas and cellulitis: Nursing
Herpes simplex virus (HSV): Nursing
Herpes zoster: Nursing
Impetigo: Nursing
Insect stings and bites: Nursing
Pediculosis and scabies: Nursing
Psoriasis: Nursing
Rocky Mountain spotted fever (RMSF): Nursing
Skin cancer - Basal cell carcinoma, squamous cell carcinoma, and melanoma: Nursing
Urticaria: Nursing
Geriatric considerations - Integumentary: Nursing
Atopic dermatitis: Nursing process (ADPIE)
Frostbite: Nursing process (ADPIE)
Methicillin-resistant Staphylococcus aureus (MRSA): Nursing process (ADPIE)
Pressure injury: Nursing process (ADPIE)
Debridement agents: Nursing pharmacology
Keratolytics: Nursing pharmacology
Antibiotics - Topical: Nursing pharmacology
Antifungals - Topical: Nursing pharmacology
Corticosteroids - Topical: Nursing pharmacology
Medications for acne vulgaris: Nursing pharmacology
Amputation: Nursing
Carpal tunnel syndrome: Nursing
Herniated intervertebral disc: Nursing
Hip fractures: Nursing
Muscular dystrophies - Duchenne and Becker: Nursing
Myasthenia gravis: Nursing
Osteoarthritis: Nursing
Osteomyelitis: Nursing
Osteoporosis: Nursing
Paget disease of bone: Nursing
Craniosynostosis: Nursing
Developmental dysplasia of the hip: Nursing
Juvenile idiopathic arthritis: Nursing
Scoliosis: Nursing
Acute compartment syndrome: Nursing process (ADPIE)
Fractures: Nursing process (ADPIE)
Gout: Nursing process (ADPIE)
Musculoskeletal injuries: Nursing process (ADPIE)
Acetylcholinesterase inhibitors for myasthenia gravis: Nursing pharmacology
Analgesics: Nursing pharmacology
Skeletal muscle relaxants: Nursing pharmacology
Altered level of consciousness (LOC): Nursing
Amyotrophic lateral sclerosis (ALS): Nursing
Bell palsy: Nursing
Cerebral palsy: Nursing
Encephalitis: Nursing
Guillain-Barré syndrome: Nursing
Head injury: Nursing
Hemorrhagic stroke - Intracranial hemorrhage (ICH) and subarachnoid hemorrhage (SAH): Nursing
Epidural and subdural hematoma: Nursing
Huntington disease: Nursing
Increased intracranial pressure (ICP): Nursing
Intracranial aneurysm: Nursing
Migraines: Nursing
Multiple sclerosis (MS): Nursing
Physiology of pain: Nursing
Spinal cord injury (SCI): Nursing
Delirium: Nursing
Dementia: Nursing
Brachial plexus injury: Nursing
Neurological assessment - Neonate: Nursing
Neural tube defects: Nursing
Meningitis: Nursing process (ADPIE)
Parkinson disease: Nursing process (ADPIE)
Seizure disorder: Nursing process (ADPIE)
Stroke: Nursing process (ADPIE)
Trigeminal neuralgia: Nursing process (ADPIE)
Antiepileptics: Nursing pharmacology
Medications for Alzheimer disease: Nursing pharmacology
Medications for migraines: Nursing pharmacology
Biology of cancer: Nursing
Bladder tumors: Nursing
Bone tumors: Nursing
Brain tumors: Nursing
Cervical cancer: Nursing
Colorectal cancer: Nursing
Esophageal cancer: Nursing
Gastric cancer: Nursing
Laryngeal cancer: Nursing
Liver cancer: Nursing
Lung cancer: Nursing
Lymphoma - Hodgkin and non-Hodgkin: Nursing
Multiple myeloma: Nursing
Neuroblastoma: Nursing
Ovarian cancer: Nursing
Pancreatic cancer: Nursing
Prostate cancer: Nursing
Renal cancer: Nursing
Retinoblastoma: Nursing
Testicular cancer: Nursing
Breast cancer: Nursing process (ADPIE)
Tumor lysis syndrome (TLS): Nursing Process (ADPIE)
Alkylating agents: Nursing pharmacology
Angiogenesis inhibitors: Nursing pharmacology
Antimetabolites: Nursing pharmacology
Antitumor antibiotics: Nursing pharmacology
Hormones and hormone modulators for cancer: Nursing pharmacology
Other antineoplastics: Nursing pharmacology
Plant extracts for chemotherapy: Nursing pharmacology
Platinum-based agents: Nursing pharmacology
Buerger disease: Nursing
Raynaud phenomenon: Nursing
Peripheral arterial disease (PAD): Nursing process (ADPIE)
Peripheral venous disease (PVD): Nursing process (ADPIE)
Contraception - Barrier methods: Nursing
Contraception - Hormonal methods: Nursing
Contraception - Natural methods: Nursing
Contraception - Permanent methods: Nursing
Endometriosis: Nursing
Genital warts: Nursing
Infertility: Nursing
Syphilis: Nursing
Gestational trophoblastic disease: Nursing
Precocious puberty: Nursing
Candidiasis: Nursing process (ADPIE)
Gonorrhea and chlamydia: Nursing process (ADPIE)
Pelvic inflammatory disease (PID): Nursing process (ADPIE)
Acute respiratory distress syndrome (ARDS): Nursing
Anthrax: Nursing
Aspergillosis: Nursing
Atelectasis: Nursing
Chest tube care: Nursing
COVID-19: Nursing
Cystic fibrosis: Nursing
Flail chest: Nursing
Influenza: Nursing
Pleural effusion: Nursing
Pleurisy: Nursing
Pneumothorax and hemothorax: Nursing
Pulmonary contusion: Nursing
Pulmonary edema: Nursing
Rib fracture: Nursing
Rupture of diaphragm: Nursing
Sarcoidosis: Nursing
Tuberculosis (TB): Nursing
Bronchopulmonary dysplasia (BPD): Nursing
Congenital diaphragmatic hernia: Nursing
Geriatric considerations - Respiratory: Nursing
Neonatal respiratory distress syndrome (NRDS): Nursing
Asthma: Nursing process (ADPIE)
Bacterial pneumonia: Nursing process (ADPIE)
Bronchiolitis and respiratory syncytial virus (RSV): Nursing process (ADPIE)
Carbon monoxide poisoning: Nursing process (ADPIE)
Chronic obstructive pulmonary disease (COPD): Nursing process (ADPIE)
Epiglottitis: Nursing process (ADPIE)
Foreign body aspiration and upper airway obstruction: Nursing process (ADPIE)
Laryngotracheobronchitis (LTB) and croup: Nursing process (ADPIE)
Smoke inhalation injury: Nursing process (ADPIE)
Venous thromboembolism (VTE): Nursing process (ADPIE)
Antihistamines: Nursing pharmacology
Bronchodilators: Nursing pharmacology
Corticosteroids - Inhaled: Nursing pharmacology
Mast cell stabilizers - Inhaled: Nursing pharmacology
Leukotriene modifiers: Nursing pharmacology
Medications to control airway secretions: Nursing pharmacology
Oxygen therapy: Nursing pharmacology
Respiratory stimulants: Nursing pharmacology
Preoperative care: Nursing
Postoperative care: Nursing
Palliative and hospice care: Nursing
Postmortem care and considerations: Nursing

Notes

MYOCARDIAL INFARCTION (MI)

KEY POINTS
NOTES
PATIENT REPORT
  • 60-year-old man
  • History hypertension
  • Chest pain
  • Feelings like elephant sitting on chest
  • ECG: ST segment elevation MI (STEMI)
  • Percutaneous coronary intervention (PCI)

PATHOPHYSIOLOGY
  • MI
    • Death of cardiac muscle tissue from prolonged ischemia
    • Risk factors
      • Over 40 years of age
      • Assigned male at birth
      • Diabetes mellitus
      • Dyslipidemia
      • Hypertension
      • Family history of MI
      • Smoking
      • Obesity
      • Sedentary
      • High fat diet
    • Causes
      • Atherosclerosis
        • Plaque builds up in coronary arteries
        • Blood supply cannot meet demands of myocardium
        • Ischemia occurs
  • Angina
    • Chest pain
    • Stable
      • Provoked by activities
      • Lasts 15 minutes or less
      • Relieved with rest or vasodilators
    • Unstable
      • Occurs without exertion
      • Lasts longer than 15 minutes
      • More severe
      • Not relieved with rest or vasodilators
  • Treatment
    • Oxygen
    • Vasodilators
    • Analgesics
    • PCI
    • Thrombolytic therapy
    • Coronary artery bypass graft (CABG)
    • Lifestyle modifications

ASSESSMENT
  • Pale, diaphoretic, anxious
  • Pain: 10/10, radiating down arm
  • Blood pressure: 168/94 mmHg
  • Heart rate: 110
  • S4 heart sound
  • ECG: ST segment elevation
  • Lung sounds clear
  • Respiratory rate: 20
  • Oxygen saturation: 94% on 4L
  • Bowel sounds active
  • Nauseated
  • Extremities cool with delayed capillary refill
  • Temperature: 99.2 F (37.2 C)
  • Troponin I, troponin T, and CK-MB increased
  • Platelets: 254,000/mm3 (254 x 109/L)
  • Hemoglobin: 16 g/dL (160 g/L)
  • Leukocytes: 13,000/mm(13 x 109/L)
  • Potassium: 3.5 mEq/L (3.5 mmol/L)
  • Creatinine: 1.0 mg/dL (88.4 μmol/L)

NURSING DIAGNOSES
  • Decreased cardiac output related to coronary artery occlusion
  • Ineffective cardiac and peripheral tissues perfusion related to reduced coronary blood flow
  • Acute pain related to myocardial ischemia
  • Anxiety related to new situational crisis
  • Deficient knowledge related to post-MI and PCI care

PLANNING
  • Cardiac output will maintain perfusion
  • No chest pain
  • Anxiety will decrease
  • Verbalize understanding of post-MI and PCI care

IMPLEMENTATION
  • Delegate vital signs
  • Administer IV morphine
  • Transport to catheterization lab and give report
  • Post-PCI
    • Monitor vital signs and ECG 
    • Monitor heart and lung sounds
    • Monitor pain
    • Monitor level of consciousness
    • Monitor anxiety
    • Monitor urine output
    • Monitor extremities 
    • Monitor peripheral pulses
    • Monitor insertion site
    • Administer medications as ordered prescribed
    • Teach about medications
    • Repositioned every 2 hours
    • Physical therapy consulted
    • Cardiac rehabilitations referral placed
    • Teach about post-MI and PCI care
    • Review lifestyle modifications

EVALUATION
  • Temperature: 98.9 F (37.1 C)
  • Heart rate: 75
  • Respiratory rate: 14
  • Lung sounds clear
  • Blood pressure: 128/70 mmHg
  • Oxygen saturation: 98% room air
  • Chest pain: 0/10
  • Insertion site pain: 2/10
  • ECG: normal sinus rhythm 
  • Skin warm and dry with brisk capillary refill 
  • Voiding pale yellow urine
  • Denies numbness to extremities
  • Peripheral pulses equal
  • Insertion site shows no bleeding, hematoma, or infection
  • Alert, oriented, less anxious
  • Troponin I, troponin T, and CK-MB peaked

Transcript

Watch video only

Miguel Garcia is a 60-year-old Hispanic male with a history of hypertension who was brought to the emergency department, or ED, for chest pain.

The pain began two hours ago and he states it feels like an elephant is sitting on his chest.

The physician just confirmed with an electrocardiogram, or ECG, that Mr. Garcia is experiencing a STEMI, which stands for ST segment elevation myocardial infarction.

The team is acting swiftly to prepare him for an emergent percutaneous coronary intervention, known as a PCI.

A myocardial infarction, also known as an MI or heart attack, refers to the death of cardiac muscle tissue from prolonged ischemia.

Risk factors include being over 40 years old or male; having diabetes mellitus, dyslipidemia, hypertension, or a family history of MIs; smoking tobacco; obesity; a sedentary lifestyle; and eating a high fat diet.

The most common cause of MI is atherosclerosis. This is when lipid containing plaque builds up in the coronary arteries.

When the coronary artery is occluded, blood and oxygen supply cannot meet the demands of the myocardium, causing ischemia.

This leads to angina, or a type of chest pain. Angina can either be stable or unstable.

Stable angina is provoked by activities that increase oxygen demand, such as exercise, lasts up to 15 minutes, and is relieved by rest or vasodilators like nitroglycerin.

This is because the occlusion limits blood flow while the oxygen demand of the myocardium increases, but when demand decreases or if the artery becomes dilated, the pain resolves

On the other hand, unstable angina can occur without exertion or even at rest, persists longer than 15 minutes, is a more severe pain than stable angina, and is not relieved by rest or vasodilators.

This is often due to the plaque rupturing which causes platelets to attach to the plaque, forming a thrombus.

The result is a more severe reduction in coronary blood flow than what occurs in stable angina, so it doesn’t resolve with rest or vasodilators.

Initially, ischemic damage is potentially reversible, but after about 20 to 40 minutes the damage is irreversible and myocardial tissue starts to necrose, causing an MI.

During an MI, the lack of blood supply to the myocardium can cause severe crushing substernal chest pain.

The pain is unprovoked, which means it occurs spontaneously regardless of activity, persists over thirty minutes, is unrelieved by rest or vasodilators like nitroglycerin, and can radiate to the shoulders, arms, jaw, neck, or back.

The myocardial oxygen supply and demand imbalance during an MI can also lead to blood pressure and heart rate changes, dysrhythmias, dyspnea, nausea, vomiting, fever, diaphoresis, a feeling of impending doom, and coolness or cyanosis of the extremities.

However, symptoms can vary greatly.

Women and elderly clients are more likely to experience atypical symptoms, and about 20 percent of MIs are silent, meaning the client was asymptomatic or attributed symptoms to another condition, such as heartburn.

The damage caused to the myocardium during an MI can lead to several complications, including arrhythmias, cardiogenic shock, pericarditis, heart failure, papillary muscle rupture, pulmonary edema, and sudden cardiac death.

If an MI is suspected based on symptoms, the next step is to diagnose it as soon as possible.

When it comes to diagnosing MIs, there are two types to keep in mind based on the ECG findings: NSTEMIs, or non ST segment elevation myocardial infarction, and STEMIs.

During an MI, the inner third of the myocardium, called the subendocardium, is affected first because it’s farthest from the coronary arteries making it more vulnerable to changes in coronary perfusion.

If the infarct is limited to the subendocardium, this is known as a subendocardial infarction and shows on an ECG with a depressed or non-elevated ST segment.

If the necrosis spreads beyond the endocardium, it’s called a transmural infarction and will have ST segment elevation on an ECG.

Other ECG findings may include the presence of inverted T waves and new Q waves during a STEMI, and T wave inversion during an NSTEMI.

For a client with unstable angina, the ECG findings are typically normal.

A clear way to differentiate between angina and a MI is with cardiac biomarkers.

Cardiac biomarkers are only present in the case of a MI because they indicate there has been irreversible damage to the myocardium.

These include troponin I, troponin T, and creatinine kinase isoenzyme MB, called CK-MB.

Troponin I and T, which are specific markers of cardiac injury, are elevated 2 to 4 hours after an infarction, peak around 48 hours, and remain elevated for 7 to 10 days.

CK-MB levels also start to rise 2 to 4 hours after an infarction, peak around 24 hours, and remain elevated for 48 hours.

Although CK-MB is not specific to cardiac injury, it is useful for identifying a reinfarction before troponin levels have returned to normal.

Because cardiac biomarkers can take several hours to be detected, they should be checked initially upon client arrival and again 6 hours later.

Now, treatment should be initiated as soon as possible when a STEMI is diagnosed to restore perfusion to the myocardium.

Oxygen should be administered to clients who are breathless, have an oxygen saturation less than 90 percent, or who have heart failure.

Chewable aspirin should be administered to slow clotting.

Vasodilators, like nitroglycerin, should be administered to foster coronary vasodilation but are contraindicated in clients with hypotension, bradycardia, or who have taken phosphodiesterase inhibitors in the past 72 hours.

Pain control increases myocardial oxygenation, so an analgesic such as morphine should be administered too.

Within 30 minutes of client arrival, a chest x-ray should be performed to detect cardiomegaly, pulmonary edema, pleural effusion, aortic dissection, or heart failure.

A complete blood count should be performed to assess for anemia and to obtain a baseline platelet count prior to initiating thrombolytic therapy.

A complete metabolic panel can reveal abnormalities in electrolytes and kidney function.

Also, clotting times may be ordered to establish baseline levels for anticoagulation therapy.

Once a STEMI is confirmed, reperfusion is needed immediately and can be accomplished through PCI; thrombolytic therapy, also called fibrinolytic therapy; or a coronary artery bypass graft, referred to as CABG.

Emergent PCI is the preferred reperfusion strategy and should be performed within 90 minutes of client arrival to the ED.

PCI involves inserting a catheter into the femoral or radial artery, injecting contrast to locate the occlusion, inflating a tiny balloon to compress the obstructing plaque, and inserting a stent to keep the artery patent.

If PCI is unavailable, thrombolytic therapy should be administered within 30 minutes of client arrival to the ED.

Thrombolytic therapy involves IV administration of a thrombolytic medication, such as reteplase, to dissolve the occluding clot.

CABG, which involves grafting a vein or artery from elsewhere in the body onto the coronary artery to bypass the blockage.

It’s not used as frequently as PCI or thrombolytic therapy but is indicated when PCI is unsuccessful.

If more than 12 hours have passed since symptom onset, reperfusion strategies are generally not performed, but PCI may be considered for clients with ongoing ischemia.

After reperfusion or if reperfusion couldn’t be done, anticoagulation agents, such as heparin, are administered, in addition to dual antiplatelet therapy using aspirin and a PY12 inhibitor like clopidogrel.

Cardioprotective medications, including angiotensin converting enzyme, or ACE inhibitors; angiotensin receptor blockers, or ARBs, for clients intolerant of ACE inhibitors; beta blockers; and statins are recommended as long term therapy after a STEMI.

Additionally, lifestyle modifications, like following a low fat and low salt diet, exercising, and smoking cessation, as well as enrolling in a cardiac rehabilitation program are important aspects of post STEMI care.

All right, let’s get back to Mr. Garcia and begin his assessment.

Upon entering his exam room, you introduce yourself, confirm his identity, and perform hand hygiene.